Could edible chemotherapy attached to milk particles someday end infusions?

August 8, 2018 by Garth Sundem, CU Anschutz Medical Campus

Generally, you can't eat chemotherapy. That's because your digestive system breaks down the molecules you eat into smaller pieces that can be absorbed through the gut into the bloodstream.

"For example, when you eat a steak or any kind of protein, you digest it and it gets chewed up into tiny amino acids that are absorbed. This is why you can't swallow vaccines or many other types of drugs; the environment in the stomach is simply too harsh. You have to get them injected or else they get chewed up," says Tom Anchordoquy, Ph.D., an investigator at University of Colorado Cancer Center and professor at the Skaggs School of Pharmacy and Pharmaceutical Sciences.

However, there is an exception to this rule.

A mother's helps the baby resist infection by giving the baby antibodies, which help the immune system to recognize and respond aggressively to certain types of infections. And, importantly, these antibodies contained in milk are not degraded by the digestive system. Instead, after they are ingested, they make their way intact into the bloodstream.

The idea that components in mother's milk avoid being completely broken down and instead deliver intact, functional molecules into a baby's bloodstream isn't entirely new. Anchordoquy points to a 2014 study in which RNA contained in special particles known as exosomes found in cow's milk were shown to alter the expression of genes in humans who drank the milk.

"But nobody believed it," Anchordoquy says. "Of course, it's common knowledge that the things you ingest are degraded, so even after this study, nobody really thought these particles in milk could survive the digestive system."

A major reason that no one believed this study is that no could understand how it could possibly work. Anchordoquy's work provides an answer.

"Your body's endothelium, including the cells that line your intestine, has these receptors that recognize antibodies on milk exosomes. These receptors in the gut bind antibodies on milk exosomes, and transport the particles across the gut into blood," Anchordoquy says. It's as if the handshake between antibody and receptor opens a tiny portal, allowing only the antibody and its attached exosome to pass. Importantly, the receptor involved in this process is present in the human gut all throughout life, not just when we are babies.

There's another very important point: "Instead of just these little particles, you can put a in them," Anchordoquy says. (Other studies, which Anchordoquy says were also not widely believed, showed that drugs incorporated into milk exosomes fed to mice could later be found in the mouse bloodstream.) These exosomes in milk encase and transport the things a mother's body wants to give to her baby. Instead, Anchordoquy hopes to encapsulate molecules of .

"Cows and humans are similar enough that cow proteins bind to the human receptors and are transported by the same mechanism. When you drink milk, cow exosomes bind to these receptors and it moves cow molecules into your blood," says Anchordoquy.

In terms of clearing the hurdles toward becoming an actual drug delivery strategy, the idea of using milk exosomes to deliver chemotherapy has two important things going for it: First, many chemotherapy drugs have already earned FDA approval for use in humans; and second, humans have consumed cow's milk for thousands of years and it is known to be safe.

Of course, a nod from the FDA to test milk-based chemotherapy isn't the only hurdle. Another challenge is the processes needed to load chemotherapeutics into these particles.

"That's the trick—the process by which you load the drug," Anchordoquy says. "That's what we've got to figure out. The real barrier here is how efficiently you can load the drug into the exosome and what drugs can you load in."

Some drugs may work, while others may not. And different variations of drug design techniques may work better with some chemotherapies than others.

Anchordoquy, along with collaborator Michael Graner, Ph.D., associate professor in the CU School of Medicine Department of Neurosurgery, were recently awarded a research grant from the National Institutes of Health to discover and design the best possible combinations. In fact, the team is already sourcing milk from Mucca Bella Dairy (Carr, CO) and running experiments to test strategies for loading drugs into milk exosomes.

"Chemotherapy requires going to the hospital. It's inconvenient, it forces cancer patients to be around other sick people, and it costs the healthcare industry billions of dollars every year. But now we have the prospect of stuffing cow's milk with chemotherapeutics," Anchordoquy says. "And who wouldn't love to just drink a glass of milk or eat an ice cream cone instead of being infused?"

Explore further: Cholesterol rafts deliver drugs inside cancer cells

Related Stories

Cholesterol rafts deliver drugs inside cancer cells

April 2, 2013
DNA, siRNA and miRNA can reprogram cancer cells – that is, if these nucleic acids could cross through the cell membrane. A University of Colorado Cancer Center study published today in the journal Therapeutic Delivery shows ...

CDC issues warning on contaminated raw milk

November 22, 2017
(HealthDay)—Individuals who may have consumed contaminated raw milk and milk products from the Udder Milk company are urged to seek medical care, according to a report published by the U.S. Centers for Disease Control and ...

Children's milk drinking habits analysed

January 19, 2018
New research shows a direct relationship between the consumption of cow's milk, and socio-demographic factors.

Milk allergy? Watch the dark chocolate

February 11, 2015
Does your sweetheart have a milk allergy? You may want to hold off on a dark chocolate Valentine.

Recommended for you

New findings cast light on lymphatic system, key player in human health

October 16, 2018
Scientists at the Oklahoma Medical Research Foundation have broken new ground in understanding how the lymphatic system works, potentially opening the door for future therapies.

Age-related increase in estrogen may cause common men's hernia

October 16, 2018
An age-related increase in estrogen may be the culprit behind inguinal hernias, a condition common among elderly men that often requires corrective surgery, according to a Northwestern Medicine study was published Oct. 15 ...

New model suggests cuffless, non-invasive blood pressure monitoring possible using pulse waves

October 16, 2018
A large team of researchers from several institutions in China and the U.S. has developed a model that suggests it should be possible to create a cuffless, non-invasive blood pressure monitor based on measuring pulse waves. ...

Discovery of inner ear function may improve diagnosis of hearing impairment

October 15, 2018
Results from a research study published in Nature Communications show how the inner ear processes speech, something that has until now been unknown. The authors of the report include researchers from Linköping University, ...

Team's study reveals hidden lives of medical biomarkers

October 12, 2018
What do medical biomarkers do on evenings and weekends, when they might be considered off the clock?

Widespread errors in 'proofreading' cause inherited blindness

October 12, 2018
Mistakes in "proofreading" the genetic code of retinal cells is the cause of a form of inherited blindness, retinitis pigmentosa (RP) caused by mutations in splicing factors.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.